05-637-AF488 Sigma-AldrichAnti-Bmi-1 Antibody, clone F6, Alexa Fluor® 488
This Anti-Bmi-1 Antibody, clone F6, Alexa Fluor® 488 is validated for use in Immunocytochemistry for the detection of Bmi-1.
More>> This Anti-Bmi-1 Antibody, clone F6, Alexa Fluor® 488 is validated for use in Immunocytochemistry for the detection of Bmi-1. Less<<Produits recommandés
Aperçu
| Replacement Information | 
|---|
Tableau de caractéristiques principal
| Species Reactivity | Key Applications | Host | Format | Antibody Type | 
|---|---|---|---|---|
| H, Mk | ICC | M | AlexaFluor®488 | Monoclonal Antibody | 
| References | 
|---|
| Product Information | |
|---|---|
| Format | AlexaFluor®488 | 
| Presentation | Purified mouse conjugate antibody in PBS with 15 mg/ml BSA and 0.1% sodium azide. | 
| Quality Level | MQ100 | 
| Physicochemical Information | 
|---|
| Dimensions | 
|---|
| Materials Information | 
|---|
| Toxicological Information | 
|---|
| Safety Information according to GHS | 
|---|
| Safety Information | 
|---|
| Storage and Shipping Information | |
|---|---|
| Storage Conditions | Stable for 1 year at 2-8°C from date of receipt. | 
| Packaging Information | |
|---|---|
| Material Size | 100 µL | 
| Transport Information | 
|---|
| Supplemental Information | 
|---|
| Specifications | 
|---|
| Global Trade Item Number | |
|---|---|
| Référence | GTIN | 
| 05-637-AF488 | 04055977277159 | 
Documentation
Anti-Bmi-1 Antibody, clone F6, Alexa Fluor® 488 FDS
| Titre | 
|---|
Anti-Bmi-1 Antibody, clone F6, Alexa Fluor® 488 Certificats d'analyse
| Titre | Numéro de lot | 
|---|---|
| Anti-Bmi-1, clone F6, Alexa Fluor® 488 - 3162854 | 3162854 | 
| Anti-Bmi-1, clone F6, Alexa Fluor® 488 - 3609317 | 3609317 | 
| Anti-Bmi-1, clone F6, Alexa Fluor® 488 - 3819924 | 3819924 | 
| Anti-Bmi-1, clone F6, Alexa Fluor® 488 -Q2595865 | Q2595865 | 
Informations techniques
| Titre | 
|---|
| Characterization of Estrogen Receptor α Phosphorylation Sites in Breast Cancer Tissue Using the SNAP i.d® 2.0 System | 
| White Paper: Further considerations of antibody validation and usage. | 

 


 
  

 

